Ubs Asset Management Americas Inc Charles River Laboratories International, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $446 Billion
  • Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 208,260 shares of CRL stock, worth $34.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208,260
Previous 283,727 26.6%
Holding current value
$34.9 Million
Previous $43 Million 24.31%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$145.57 - $178.99 $11 Million - $13.5 Million
-75,467 Reduced 26.6%
208,260 $32.6 Million
Q2 2025

Aug 14, 2025
BUY
$99.75 - $151.89 $3.7 Million - $5.63 Million
37,099 Added 15.04%
283,727 $43 Million
Q1 2025

May 19, 2025
SELL
$150.52 - $190.14 $7.77 Million - $9.82 Million
-51,622 Reduced 17.31%
246,628 $37.1 Million
Q4 2024

Feb 14, 2025
BUY
$178.58 - $220.69 $8.39 Million - $10.4 Million
46,994 Added 18.7%
298,250 $55.1 Million
Q3 2024

Nov 14, 2024
SELL
$187.96 - $245.29 $2.63 Million - $3.43 Million
-14,003 Reduced 5.28%
251,256 $49.5 Million
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $9.2 Million - $12 Million
44,573 Added 20.2%
265,259 $54.8 Million
Q1 2024

May 15, 2024
BUY
$203.52 - $273.43 $151,011 - $202,885
742 Added 0.34%
220,686 $59.8 Million
Q4 2023

Feb 14, 2024
BUY
$164.52 - $238.84 $9.76 Million - $14.2 Million
59,353 Added 36.96%
219,944 $52 Million
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $2.93 Million - $3.28 Million
15,062 Added 10.35%
160,591 $31.5 Million
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $3.24 Million - $4.38 Million
16,865 Added 13.11%
145,529 $29.4 Million
Q4 2022

Feb 14, 2023
SELL
$197.11 - $250.07 $100,131 - $127,035
-508 Reduced 0.39%
128,664 $28 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $1.26 Million - $1.73 Million
-6,921 Reduced 5.09%
129,172 $25.4 Million
Q2 2022

Aug 12, 2022
SELL
$204.13 - $302.4 $650,358 - $963,446
-3,186 Reduced 2.29%
136,093 $29.1 Million
Q1 2022

May 16, 2022
SELL
$255.51 - $362.11 $910,893 - $1.29 Million
-3,565 Reduced 2.5%
139,279 $39.6 Million
Q4 2021

Feb 14, 2022
BUY
$351.38 - $448.68 $1.35 Million - $1.72 Million
3,839 Added 2.76%
142,844 $53.8 Million
Q3 2021

Nov 15, 2021
BUY
$372.64 - $458.3 $3.05 Million - $3.75 Million
8,172 Added 6.25%
139,005 $57.4 Million
Q2 2021

Aug 16, 2021
BUY
$294.17 - $371.65 $14.6 Million - $18.4 Million
49,616 Added 61.09%
130,833 $48.4 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $2.62 Million - $3.14 Million
-10,479 Reduced 11.43%
81,217 $23.5 Million
Q4 2020

Mar 01, 2021
BUY
$222.0 - $252.62 $2.5 Million - $2.85 Million
11,266 Added 14.01%
91,696 $22.9 Million
Q3 2020

Nov 13, 2020
SELL
$175.56 - $226.45 $13.4 Million - $17.3 Million
-76,351 Reduced 48.7%
80,430 $18.2 Million
Q2 2020

Aug 14, 2020
BUY
$118.84 - $189.72 $2.57 Million - $4.1 Million
21,620 Added 16.0%
156,781 $27.3 Million
Q1 2020

May 15, 2020
BUY
$98.9 - $178.34 $3.37 Million - $6.08 Million
34,073 Added 33.71%
135,161 $17.1 Million
Q4 2019

Feb 14, 2020
SELL
$126.05 - $152.76 $4.33 Million - $5.24 Million
-34,331 Reduced 25.35%
101,088 $15.4 Million
Q3 2019

Nov 14, 2019
BUY
$125.07 - $143.67 $1.85 Million - $2.12 Million
14,765 Added 12.24%
135,419 $17.9 Million
Q2 2019

Aug 15, 2019
BUY
$123.4 - $148.55 $2.99 Million - $3.6 Million
24,241 Added 25.14%
120,654 $0
Q1 2019

May 14, 2019
BUY
$104.82 - $146.73 $715,082 - $1 Million
6,822 Added 7.61%
96,413 $0
Q4 2018

Feb 13, 2019
SELL
$105.09 - $137.23 $215,959 - $282,007
-2,055 Reduced 2.24%
89,591 $10.1 Million
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $177,918 - $213,514
1,587 Added 1.76%
91,646 $0
Q2 2018

Aug 14, 2018
SELL
$102.37 - $117.25 $467,626 - $535,598
-4,568 Reduced 4.83%
90,059 $0
Q1 2018

May 14, 2018
SELL
$98.19 - $115.2 $21,994 - $25,804
-224 Reduced 0.24%
94,627 $0
Q4 2017

Feb 09, 2018
SELL
$100.43 - $118.09 $2.09 Million - $2.45 Million
-20,764 Reduced 17.96%
94,851 $0
Q3 2017

Nov 13, 2017
BUY
$96.72 - $109.26 $11.2 Million - $12.6 Million
115,615
115,615 $0

Others Institutions Holding CRL

# of Institutions
644
Shares Held
51.6M
Call Options Held
194K
Put Options Held
174K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email